SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-058996
Filing Date
2017-11-14
Accepted
2017-11-14 16:05:03
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv478298_10q.htm 10-Q 473628
2 EXHIBIT 10.1 tv478298_ex10-1.htm EX-10.1 21480
3 EXHIBIT 31.1 tv478298_ex31-1.htm EX-31.1 9720
4 EXHIBIT 32.1 tv478298_ex32-1.htm EX-32.1 5237
  Complete submission text file 0001144204-17-058996.txt   3676939

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgrx-20170930.xml EX-101.INS 922586
6 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20170930.xsd EX-101.SCH 33407
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20170930_cal.xml EX-101.CAL 20202
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20170930_def.xml EX-101.DEF 190954
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20170930_lab.xml EX-101.LAB 232831
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20170930_pre.xml EX-101.PRE 220045
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 171201447
SIC: 2834 Pharmaceutical Preparations